Phase 1 Psoriasis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For the single-dose part of the study (SAD):
- You are a healthy adult between 18 and 45 years old
- You meet the weight requirements: men must weigh at least 50 kg and women at least 45 kg, and everyone must weigh 110 kg or less, with a BMI between 18 and 28
- Your general health checks — including physical exam, heart tracing (ECG), blood tests, ultrasound, and chest X-ray — come back normal or with no important concerns
For the multiple-dose part of the study (MAD):
- You are a male or female adult between 18 and 65 years old
- You meet the same weight requirements as above
- You have had chronic plaque psoriasis for at least 6 months, with or without psoriatic arthritis (a related joint condition)
Who may not be able to join:
For the single-dose part of the study (SAD):
- You have a history of immune system-related diseases or conditions
- You have a history of drug allergies or other significant allergies that the study doctor believes could put you at risk, or you may be allergic to the study drug or its ingredients
- You have a history of drug misuse in the past 5 years, used illegal drugs in the past 3 months, or test positive on a urine drug screen
For the multiple-dose part of the study (MAD):
- You have a type of psoriasis other than chronic plaque psoriasis, such as guttate, pustular, or erythrodermic psoriasis, or psoriasis caused by a medication
- You are currently taking, or have recently taken, certain medications that are not allowed in this trial (confirm with trial site for the specific list and timeframes)
- You have a history of repeated or long-term infections, serious infections such as blood poisoning or pneumonia, or have been hospitalised or treated with intravenous antibiotics for an infection within the past 2 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 13750837205
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence, sever ity and association with the study drug of adverse events (AEs), serious AEs (SAEs), and AEs leading to discontinuation; Number of participants with abnormalities of physical examination; Number of participants with abnormalities of vital signs; Number of participants with clinical laboratory abnormalities; Number of participants with abnormalities of electrocardiogram (ECG) parameters
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.